pyrazines has been researched along with Brain Injuries in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jin, M; Liu, S; Ma, X; Shao, Z; Shi, H; Wang, X; Wu, P | 1 |
Du, S; He, G; Sun, Z; Wu, Y; Zhang, X; Zhao, Y; Zhou, L; Zhou, P; Zhuo, LH | 1 |
Brandstetter, M; Engelhard, K; Förster, CY; Neuhaus, W; Schaible, EV; Scheffer, D; Thal, SC; Wunder, C | 1 |
Chen, H; Gao, C; Liu, W; Liu, X; Shi, H; Zhao, S; Zhao, Z | 1 |
Ju, Y; Liu, WK; Ma, L; Zhang, YK | 1 |
Chen, J; Chopp, M; Jiang, H; Mahmood, A; Ning, R; Qu, C; Xiong, Y; Zhang, L | 1 |
Kawai, N; Kawanishi, M; Nagao, S | 1 |
Auguet, M; Chabrier, PE; Demerlé-Pallardy, C | 1 |
Auguet, M; Auvin, S; Bigg, D; Chabrier, PE; Cornet, S; Demerlé-Pallardy, C; Gillard-Roubert, V; Guilmard-Favre, C; Marin, JG; Moncada, S; Pignol, B; Roussillot-Charnet, C; Schulz, J; Spinnewyn, B; Viossat, I | 1 |
Birraux, G; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Genevois-Borella, A; Jimonet, P; Mignani, S; Pratt, J; Stutzmann, JM; Vuilhorgne, M; Wahl, F | 1 |
1 review(s) available for pyrazines and Brain Injuries
Article | Year |
---|---|
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes | 1999 |
9 other study(ies) available for pyrazines and Brain Injuries
Article | Year |
---|---|
Tetramethylpyrazine Protects Against Early Brain Injury and Inhibits the PERK/Akt Pathway in a Rat Model of Subarachnoid Hemorrhage.
Topics: Animals; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; eIF-2 Kinase; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage; Vasodilator Agents | 2018 |
Tetramethylpyrazine‑2'O‑sodium ferulate provides neuroprotection against neuroinflammation and brain injury in MCAO/R rats by suppressing TLR-4/NF-κB signaling pathway.
Topics: Animals; Brain Edema; Brain Injuries; Chemokine CCL2; Cytokines; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammation; Intercellular Adhesion Molecule-1; Male; Neuroprotective Agents; Nitric Oxide Synthase Type II; Pyrazines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA | 2019 |
Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury.
Topics: Animals; Blood Gas Analysis; Blood-Brain Barrier; Blotting, Western; Boronic Acids; Bortezomib; Brain Edema; Brain Injuries; Dexamethasone; Disease Models, Animal; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Multivariate Analysis; Proteasome Endopeptidase Complex; Pyrazines; Random Allocation; Real-Time Polymerase Chain Reaction; Receptors, Glucocorticoid; Reference Values; RNA, Messenger; Sensitivity and Specificity; Statistics, Nonparametric | 2013 |
Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Behavior, Animal; Blotting, Western; Brain Edema; Brain Injuries; Caspase 3; Cerebral Cortex; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intravenous; Male; Motor Activity; Neuroprotective Agents; Pyrazines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors; Tumor Suppressor Protein p53; Vasodilator Agents; Vasospasm, Intracranial | 2008 |
[Impacts of tetramethylpyrazine on BDNF, bFGF expression and neuron-protection in severe brain injury tissue of rat].
Topics: Animals; Brain Injuries; Brain-Derived Neurotrophic Factor; Female; Fibroblast Growth Factor 2; Immunohistochemistry; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
The treatment of traumatic brain injury with velcade.
Topics: Animals; Boronic Acids; Bortezomib; Brain Injuries; Disease Models, Animal; Male; Pyrazines; Rats; Rats, Wistar; Spatial Behavior; Treatment Outcome | 2010 |
Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats.
Topics: Animals; Blood-Brain Barrier; Body Water; Brain; Brain Edema; Brain Injuries; Capillary Permeability; Cold Temperature; Enzyme Inhibitors; Hydroxamic Acids; Male; Matrix Metalloproteinase Inhibitors; Parietal Lobe; Pyrazines; Rats; Rats, Sprague-Dawley; Staining and Labeling; Sulfonamides | 2003 |
BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy.
Topics: Animals; Aorta; Brain Injuries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gerbillinae; Inhibitory Concentration 50; Kinetics; Lipid Peroxidation; Male; Mice; Myocardial Ischemia; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Organ Culture Techniques; Pyrazines; Rats; Rats, Sprague-Dawley; Thiophenes; Time Factors | 1999 |
9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.
Topics: Animals; Anticonvulsants; Brain Injuries; Brain Ischemia; Disease Models, Animal; Gerbillinae; Imidazoles; Male; Neuroprotective Agents; Oocytes; Protein Binding; Pyrazines; Radioligand Assay; Rats; Receptors, AMPA; Reperfusion Injury; Seizures; Spinal Cord Compression; Synapses; Xenopus | 2002 |